Efficacy of the Jingxin Zhidong Formula for Tic Disorders: A Randomized, Double Blind, Double Dummy, Parallel Controlled Trial

Fei Fan, Long Hao, Si Zhang, Ying Zhang, Zhaoxiang Bian, Xuan Zhang, Qiong Wang, Fei Han*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background

The Jingxin Zhidong formula (JXZDF), a traditional Chinese medicine, has been widely used to treat tic disorder (TD) in China. However, its efficacy has not yet been evaluated in a randomized controlled trial. We aimed to compare the effectiveness and safety of JXZDF and aripiprazole in patients with TD. 

Methods

In this randomized, double-blind, double-dummy, parallel controlled trial, 120 patients with TD, aged 6–16 years were randomly assigned to receive either JXZDF (n = 60, 17.6 g/day) or aripiprazole (n = 60, 10 mg/day) for 12 weeks. The primary outcome was measured using the Yale Global Tic Severity Scale (YGTSS). Adverse events were assessed using the Treatment Emergent Symptom Scale. 

Results

JXZDF produced greater improvements than aripiprazole in the following YGTSS subscale scores at the endpoint: total tic scores (P = 0.004, 95% CI: 1.085–3.494) and total motor scores (P = 0.004, 95% CI: 0.313–1.739). The difference in rate between the groups was no significant (χ2 = 0.702, degrees of freedom = 1, P = 0.402). The overall incidence of adverse events was significantly lower in the JXZDF group than in the aripiprazole group (0% vs 6.67%, P < 0.001). 

Conclusion

JXZDF had a better safety profile than aripiprazole, and it was not inferior in terms of clinical efficacy. JXZDF warrants consideration as a potential treatment option for TD.

Original languageEnglish
Pages (from-to)57-66
Number of pages10
JournalNeuropsychiatric Disease and Treatment
Volume18
DOIs
Publication statusPublished - Jan 2022

Scopus Subject Areas

  • Psychiatry and Mental health
  • Biological Psychiatry

User-Defined Keywords

  • Chinese herbal Medicine formula
  • Jingxin Zhidong formula
  • Randomized controlled trial
  • Tic disorder
  • Tourette syndrome

Fingerprint

Dive into the research topics of 'Efficacy of the Jingxin Zhidong Formula for Tic Disorders: A Randomized, Double Blind, Double Dummy, Parallel Controlled Trial'. Together they form a unique fingerprint.

Cite this